Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada
Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in CanadaView Video
Roundtable Discussion; The Future of Mineral Sands
Roundtable Discussion; The Future of Mineral SandsView Video

Latest Share Chat

Pin to quick picksAdvanced Oncotherapy Share News (AVO)

  • This share is currently suspended. It was suspended at a price of 1.925

Share Price Information for Advanced Oncotherapy (AVO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.925
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.925
AVO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: THG Surges After Raising Revenue Guidance

Mon, 26th Oct 2020 10:35

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.

----------

FTSE 100 - WINNERS

----------

Pearson, up 3.6%. UBS upgraded the education publisher to Buy from Neutral.

----------

AstraZeneca, up 1.1%. The Anglo-Swedish drugmaker late Friday said clinical trials for its AZD1222 coronavirus vaccine, being developed alongside Oxford University, has been resumed around the world, as regulators in the US, UK, Brazil, South Africa and Japan confirmed that it is safe to do so. The US Food & Drug Administration authorised the restart of the trials in the US, as they resumed in other countries in recent weeks, following the review of all safety data from trials in other regions.

----------

FTSE 100 - LOSERS

----------

Royal Dutch Shell 'A', down 1.6%, Shell 'B', down 1.5%. The oil major was tracking spot oil prices lower, quoted at USD40.78 a barrel Monday morning, down sharply from USD42.25 late Friday. Warring factions in Libya signed a countrywide ceasefire on Friday brokered by the United Nations. The ceasefire is poised to lead to more Libyan oil supply to the market at a time when demand is weak. "The return of just one million barrels per day of extra production to the world market has sent oil into a tailspin. It highlights how fragile sentiment is to the supply/demand balance of oil in international markets. A double-dip recession in Europe will add to the demand concerns," said Oanda Markets analyst Jeffery Halley.

----------

FTSE 250 - WINNERS

----------

Synthomer, up 2.5%. JPMorgan raised the speciality chemicals firm to Overweight from Neutral.

----------

FTSE 250 - LOSERS

----------

Beazley, down 2.5%. Morgan Stanley downgraded the insurer to Equal Weight from Overweight.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

THG Holdings, up 12%. The online retailing platform raised revenue guidance for 2020, following strong trading in the third quarter and continued momentum in the fourth quarter to date. THG said for the three months to the end of September, total revenue grew by 39% year-on-year to GBP378.1 million. The group reported growth across all businesses. The largest contributor was THG Beauty, which grew revenue by 45% to GBP157.5 million. However, it was the THG Lifestyle division which grew at the fastest percentage rate, with an 80% increase to GBP24.4 million. THG listed in London last month with a market capitalisation of GBP5.40 billion and at the time guided for annual revenue of GBP1.43 billion. As a result of the stronger quarterly performance, the group now expects revenue to be between GBP1.48 billion to GBP1.52 billion, reflecting a 30% to 33% increase from GBP1.14 billion the year before. "Longer-term excitement around the story is based on its Ingenuity platform which has been compared in some quarters to Ocado's online solution for global groceries firms. The Hut essentially picking up the IT and logistical requirements of the likes of PZ Cussons, Hotel Chocolat and Nestle," said AJ Bell's Russ Mould.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Advanced Oncotherapy, down 14% at 31.65 pence. The proton therapy provider said it intends to raise GBP7.7 million through a subscription, the proceeds of which will go towards strengthening the company's balance sheet and ensure its first LIGHT system is fully operational in 2021. The company said it will issue 25.7 million shares to clients of SI Capital and other investors at a price of 30p each. The issue price reflects a 18% discount to the company closing price on Friday at 37p. The newly issued shares will represent 7.7% of its enlarged issued share capital.

----------

Corcel, down 11% at 1.07 pence. The natural resource exploration and development company said it has raised GBP750,000 through the placing of 75 million shares at GBP0.01 per share. The placing price represents a 15% discount to Friday's closing price of 1.17 pence. London-based Corcel said the new cash will be used to exercise the option with Sinom Hong Kong Ltd to purchase the remaining AUD3.05 million - or GBP1.7 million - debt in Resource Mining Corp at a 65% discount, noting the the exercise of the option now entails the payment of AUD640,000 in cash and the issuance of 23.7 million shares to Sinom subsidiary Asia Pacific. The company added it will also use some of the proceeds to pursue additional opportunities in the battery metals space.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
28 Nov 2022 15:45

Advanced Oncotherapy study delivers lower radiation for proton therapy

(Alliance News) - Advanced Oncotherapy PLC on Monday said that a recently-completed study has shown the potential superiority of its proton therapy in treating breast cancer patients.

Read more
6 Oct 2022 20:10

TRADING UPDATES: ImmuPharma loss narrows; MetalNRG loss widens

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
27 Sep 2022 22:07

TRADING UPDATES: Goldstone Resources hails results; PCF moves deadline

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
19 Aug 2022 11:48

Advanced Oncotherapy raises another £1.47m as it advances 'LIGHT' system

(Sharecast News) - Proton therapy developer Advanced Oncotherapy announced it was raising £1.47m through a direct subscription on Friday, to fund its corporate activities as it moves its 'LIGHT' system towards full operation.

Read more
19 Aug 2022 09:18

Advanced Oncotherapy shares rise on GBP1.5 million fundraise

(Alliance News) - Shares in Advanced Oncotherapy PLC jumped on Friday following its announcement of a GBP1.5 million equity fundraise.

Read more
3 Aug 2022 21:21

IN BRIEF: Advanced Oncotherapy raises GBP550,691 for working capital

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Raises GBP550,691 through direct subscription of 2.2 million shares at a price of 25 pence per share.

Read more
30 Jun 2022 12:11

EARNINGS UPDATES: Accsys profit up, Dolphin Capital loss narrows

(Alliance News) - The following is a round-up of earnings reports by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
28 Jun 2022 20:09

IN BRIEF: Advanced Oncotherapy raises GBP6.0 million in subscription

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Raises GBP6.0 million before expenses in subscription for 24.1 million shares at 25 pence each. The issue price was a premium of 19% to the closing middle market price of a share on Monday. Notes Odey Asset Management LLP subscribed for GBP4.5 million in shares, on behalf of some of its funds.

Read more
26 Apr 2022 20:36

IN BRIEF: Advanced Oncotherapy system optimised to sub-millimetre size

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Says it has made "significant" progress with the commissioning of the Light system. This includes Light system beam being optimised to a sub-millimetre size, with a beam current of about 50 microamperes; and 20 of the 21 accelerating modules have been radio-frequency conditioned.

Read more
25 Mar 2022 18:51

TRADING UPDATES: Europa eyes fundraise; Eastinco extends long stop

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
25 Mar 2022 13:18

Advanced Oncotherapy raises £2m for proton therapy development

(Sharecast News) - Proton therapy technology developer Advanced Oncotherapy announced an equity fundraise of £2m on Friday, to fund itself along its revised timetable for the development of the 'LIGHT' cancer therapy system.

Read more
4 Mar 2022 20:53

TRADING UPDATES: IOG to cut Gazprom ties; wholesale changes at Donegal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and Tuesday and not separately reported by Alliance News:

Read more
30 Sep 2021 11:21

TRADING UPDATES: Avation wings clipped by virus; Zaim swings to profit

TRADING UPDATES: Avation wings clipped by virus; Zaim swings to profit

Read more
11 Aug 2021 19:54

TRADING UPDATES: Ince launches solution; PureTech gets USD6.5 million

TRADING UPDATES: Ince launches solution; PureTech gets USD6.5 million

Read more
30 Jul 2021 15:34

EXECUTIVE CHANGES: All change for ImmuPharma board as CEO departs

EXECUTIVE CHANGES: All change for ImmuPharma board as CEO departs

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.